Both the manufactures of Nemagon and the U.S. government have been aware of its sterility and carcinogenic effects since the 1950's. Yet it wasn't until 1977 when workers at an Occidental plant noticed that they all were sterile, that the true effects of Nemagon became painfully clear. In the midst of the news storm that followed the discovery- Dow and Shell closed down production of DBCP.